Inventor

Lorin K. Johnson

Inventor
Pleasanton, CA, US

Overview

19→
Patents
1986–2015
Patent span
Human necessities
Primary field (CPC A)

Patents· 19 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary
A61KPreparations for medical, dental or toiletry purposes32%
C07KPeptides19%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations14%
C12NMicroorganisms or enzymes12%
Y02ATechnologies for adaptation to climate change7%
A23LFoods, foodstuffs or non-alcoholic beverages, not otherwise provided for5%
A23PShaping or working of foodstuffs, not fully covered by a single other subclass5%
Y10STechnical subjects covered by former uspc cross-reference art collections [xracs] and digests5%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms2%
PatentTitleYear
9,192,616'Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives'20158,921,344'Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives'20148,497,256'Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives for the treatment of males'20138,309,569'Methods for treating diarrhea-associated irritable bowel syndrome'20127,625,884'Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives'20097,452,872'Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives'20085,905,073'Use of 2-hydroxy-5-phenylazobenzoic acid derivatives as colon cancer chemopreventative and chemotherapeutic agents'19995,646,254'Antibodies for human phospholipase inhibitory protein (hPIP)'19975,552,530'Antibodies that specifically bind to and inhibit human synovial phospholipase A.sub.2 type A'19965,498,608'Use of 2-hydroxy-5-phenylazobenzoic acid derivatives as colon cancer chemopreventative and chemotherapeutic agents'19965,342,764'Recombinant expression system for human anti-inflammatory phospholipase inhibitor protein'19945,264,550'Human anti-inflammatory phospholipase inhibitor protein'19935,047,397'Linear analogs of atrial natriuretic peptides'19915,019,508'Synovial phospholipases'19914,935,492'Cyclic analogs of atrial natriuretic peptides'19904,804,650'Analogs of atrial natriuretic peptides'19894,764,504'Novel atrial natriuretic/vasodilator polypeptides'19884,757,048'Synthetic analogs of atrial natriuretic peptides'19884,618,600'Novel polypeptide diuretic/vasodilators'1986

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1986–1989Patents assigned to BIOTECHNOLOGY RES ASS (4)· patent assignee history
1986–1988Based in Castro Valley, CA, US· patent location history
1988–1999Based in Pleasanton, CA, US· patent location history
1993–1997Patents assigned to SCIOS NOVA INC (3)· patent assignee history
1999–2015Patents assigned to SALIX PHARMACEUTICALS INC (4)· patent assignee history
2008–2015Based in Palo Alto, CA, US· patent location history
2009–2013Patents assigned to SALIX PHARMACEUTICALS LTD (3)· patent assignee history
2012–2015Patents assigned to JOHNSON LORIN (4)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
BIOTECHNOLOGY RES ASS41986–1989
JOHNSON LORINself42012–2015
SALIX PHARMACEUTICALS INC41999–2015
SALIX PHARMACEUTICALS LTD32009–2013
SCIOS NOVA INC31993–1997
Locations
LocationPatentsSpan
Pleasanton, California, US111988–1999
Palo Alto, California, US62008–2015
Castro Valley, California, US21986–1988